Navigation Links
Cubist Pharmaceuticals Becomes First Company to Implement Integrated Reprints Desk Document Delivery and QUOSA Scientific Literature Workflow Solution
Date:12/9/2009

SANTA MONICA, Calif. and WALTHAM, Mass., Dec. 10 /PRNewswire/ -- Reprints Desk, Inc., and QUOSA, Inc., today announced that Cubist Pharmaceuticals has become the first shared customer to activate integration between Reprints Desk's STM Document Delivery service with QUOSA's Virtual Library, which facilitates copyright-compliant article archiving and scientific literature re-use. The integrated solution features integration with Rightsphere, the rights advisory and management tool from Copyright Clearance Center (CCC), which already integrates independently with both Reprints Desk and QUOSA.

"The integration of QUOSA's powerful solution for archiving and sharing scientific journal articles with Reprints Desk's ultra-rapid document delivery service was a logical collaboration for delivering the efficiency and compliance benefits we've been seeking to enhance our eLiterature services," said A. Amyas Huston, Senior Manager of Medical Communications at Cubist. "With QUOSA already deployed and Reprints Desk delivery not requiring any platform fees or any IT information technology involvement from Cubist, the implementation within our workflow processes was fast and seamless."

Lexington MA-based Cubist Pharmaceuticals has been a QUOSA customer and a Reprints Desk customer since 2007. QUOSA serves a large and rapidly growing subscriber-base at leading pharmaceutical, biotechnology and other life-science companies, with solutions for efficiently managing and monitoring scientific literature. Reprints Desk earned the top ranking overall and in every category in the 2008 Document Delivery Best Practices and Vendor Scorecard by analyst and advisory firm Outsell, Inc., and scored a 97% customer satisfaction rating in Dun & Bradstreet's 2009 Open Ratings survey of existing Reprints Desk customers.

For more information about Reprints Desk and its STM Document Delivery service, visit the Reprints Desk website online at www.reprintsdesk.com. For additional information about QUOSA's solutions for efficiently managing and monitoring scientific literature and the QUOSA Virtual Library, visit www.quosa.com.

About QUOSA®

QUOSA Inc. is a specialist software company focused on literature management workflows and archives, which include full-text articles and patents. With a large and rapidly growing subscriber-base at leading pharmaceutical, biotechnology and other life-science companies, and in research and medical centers, QUOSA's applications are used to compress the time to insight and action across the key functions of the innovation enterprise. For more information about QUOSA, please visit the website at www.quosa.com.

About Reprints Desk®

Reprints Desk, Inc. (www.reprintsdesk.com) is a business software and information services company that simplifies how research-intensive companies and other organizations procure, manage and share journal articles and other copyright-protected content. The company's content workflow and compliance solutions help customers effectively use peer-reviewed literature in research, regulatory submissions, and product promotions. A channel supplier for more than 100 scientific, technical, and medical (STM) publishers, Reprints Desk earned the #1 ranking in the 2008 Document Delivery Vendor Scorecard by Outsell, Inc., and currently serves companies in life sciences, energy, aerospace, industrial products, consumer packaged goods, food and beverages, information technology, legal, and government. Reprints Desk is a Derycz Scientific company. For more information about Reprints Desk, contact Ian Palmer at +1 (707) 658-1931.


Public and Media Relations Contacts:
------------------------------------

Ian Palmer, Head of Marketing
Reprints Desk, Inc. | +1 707.658.1931
ipalmer@reprintsdesk.com

SOURCE Reprints Desk, Inc.


'/>"/>
SOURCE Reprints Desk, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Anesiva Completes Sale of its Zingo(TM) Assets to Powder Pharmaceuticals and Lees Pharmaceuticals
2. BioCryst Pharmaceuticals Elects Charles A. Sanders to its Board of Directors
3. ADVENTRX Pharmaceuticals to Present at the Lippert/Heilshorn Life Sciences Virtual Conference
4. Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis
5. Rib-X Pharmaceuticals Expands License Agreement with Yale University on New Ribosome Technology
6. Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology
7. Successful Phase I/II Clinical Trial for BiondVax Pharmaceuticals Universal Flu Vaccine
8. Onyx Pharmaceuticals to Host American Society of Hematology (ASH) Investor Teleconference
9. BioMed Realty Trust Signs New Lease With Regeneron Pharmaceuticals for 131,000 Square Feet at Landmark
10. Jazz Pharmaceuticals Appoints Kathryn Falberg as Chief Financial Officer
11. Amira Pharmaceuticals Announces Initial Positive Phase 1 Clinical Data for AM461, A Back-Up to Amiras Lead DP2 Antagonist, AM211
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... ITL Limited, ( ASX : ITD ), une société de ... excellents résultats semestriels clos le 31 décembre 2016 par ... « Résultats et mise à jour sur la croissance biomédicale ... Faits marquants Bénéfice ... hausse de 104 %) Bénéfice par action ...
(Date:2/24/2017)... 23, 2017 Non-alcoholic steatohepataitis (NASH) ... various drugs being developed for the treatment ... drugs that are in various phases of ... focuses on novel pharmacologic drugs & regenerative ... therapies, recombinant proteins and RNA-based therapeutics, but ...
(Date:2/24/2017)... Feb. 24, 2017  Xynomic Pharmaceuticals, Inc., an oncology ... it has acquired exclusive worldwide rights to develop, ... HDAC inhibitor targeting hematological and solid tumors. ... 1 and 2 clinical trials of Abexinostat in ... have already been completed, demonstrating that Abexinostat is ...
Breaking Medicine Technology:
(Date:2/26/2017)... ... February 26, 2017 , ... ... technology standard in staffing, scheduling, and reporting for healthcare organizations. This comprehensive ... throughout the entire staffing process. StaffBridge technology improves staffing efficiency, maximizes resource ...
(Date:2/24/2017)... MN (PRWEB) , ... February 24, 2017 , ... ... of its newly designed TaskMate Go. Core benefits and advantages built into the ... and a stylish, functional look and feel. Ability to gain the benefits embedded ...
(Date:2/24/2017)... ... February 24, 2017 , ... Dr. Ronald ... officially announced the appointment of Peter A. Bell, DO, MBA, HPF, FACOEP-dist., FACEP, ... (LUCOM), beginning April 10. Dr. Bell comes to Liberty from the Ohio University ...
(Date:2/24/2017)... ... February 24, 2017 , ... The narrative in “ Signal 8: ... ’s true account of his paramedic experiences. Schanssema describes the tragedies he saw, as ... attempts to overcome them. , Schanssema, initially unsure of the career path he wanted ...
(Date:2/24/2017)... ... February 24, 2017 , ... Indiana Fiber Network (IFN) President ... later this year. Dyer started as the Chairman of the Management Committee when ... of the corporation including the recruitment of investor/owners and development of the business plan. ...
Breaking Medicine News(10 mins):